Keyphrases
Acute Myeloid Leukemia
100%
FMS-like Tyrosine Kinase 3 (FLT3)
100%
Internal Tandem Duplication
100%
RSK1
100%
Leukemia
25%
USP1
25%
Phosphorylation
12%
Apoptosis
12%
Multivariate Analysis
12%
Signaling Cascades
12%
Genetic Modification
12%
Breast Cancer
12%
Downstream Signaling
12%
Disease Burden
12%
Syngeneic
12%
S6 Kinase 1 (S6K1)
12%
Therapeutic Response
12%
Cycloheximide
12%
Patient Survival
12%
Xenograft
12%
Therapeutic Strategies
12%
De Novo Acute Myeloid Leukemia
12%
Acute Myeloid Leukemia Cells
12%
Leukemia Model
12%
MG132
12%
Patient Prognosis
12%
First-in-class
12%
Leukemia Cell Lines
12%
Activity Stability
12%
Protein Stability
12%
Survival Response
12%
MV4-11
12%
Bidirectional Regulation
12%
Ubiquitination Assay
12%
RSK Inhibitor
12%
RPS6KA1
12%
Biochemistry, Genetics and Molecular Biology
Receptor Tyrosine Kinase
100%
Tyrosine Kinase
100%
Myeloid
100%
USP1
25%
Kinase
12%
Phosphotransferase
12%
Gene Mutation
12%
Multivariate Analysis
12%
Cycloheximide
12%
Syngenic
12%
Ubiquitination
12%
Disease Burden
12%
Ribosomal Protein S6
12%
Protein Stability
12%
Programmed Cell Death
12%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
CD135 Antigen
100%
Leukemia
25%
Biological Marker
12%
Treatment Response
12%
Gene Mutation
12%
Disease Burden
12%
Breast Cancer
12%
Programmed Cell Death
12%
Multivariate Analysis
12%
Cycloheximide
12%
Xenograft
12%
Ubiquitination
12%
De Novo Acute Myeloid Leukemia
12%
Acute Myeloid Leukemia Cell Line
12%
Protein Stability
12%
S6 Kinase
12%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
CD135 Antigen
100%
Leukemia
25%
Biological Marker
12%
Breast Cancer
12%
S6 Kinase
12%
Cycloheximide
12%
De Novo Acute Myeloid Leukemia
12%
Diseases
12%